Literature DB >> 8086262

MR imaging in cerebral gliomas. Tissue component analysis in correlation with histopathology of whole-brain specimens.

M Tovi1, M Hartman, A Lilja, A Ericsson.   

Abstract

A comparative analysis between MR examinations and histopathologic whole-brain sections regarding tumour components was performed in 5 brain specimens from patients with malignant glial brain tumours. All cases were examined with MR imaging in vitro and in 2 cases a close comparison with the MR examinations in vivo was also possible. The most homogeneous hypercellular area in malignant gliomas, giving the highest tumour grade, was not visualised on MR imaging as an isolated entity, either in vitro or in vivo. The most conspicuous tumour component, reflecting the heterogeneity of malignant gliomas, was necrosis. This feature was best depicted in the T2WI. In 4 of 5 cases, distant tumour spread of benign-looking tumour cells was found in areas visualised as normal on T2WI, outside the margins of the peritumoural oedema. In 2 cases, estimation of water content was performed immunohistochemically and a close correlation was found in each case between peritumoural and periventricular hyperintensity on T2WI and areas of pallor on the haematoxylin-eosin-stained whole-brain sections. These areas corresponded to microscopical oedema. MR imaging reflects underlying heterogeneous histopathology in malignant gliomas. The degree of malignancy of the lesion as a whole can thus be assessed by MR imaging. However, the method does not allow malignant gliomas to be correctly delineated.

Entities:  

Mesh:

Year:  1994        PMID: 8086262

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  15 in total

Review 1.  A review of the automated detection of change in serial imaging studies of the brain.

Authors:  Julia Patriarche; Bradley Erickson
Journal:  J Digit Imaging       Date:  2004-06-29       Impact factor: 4.056

2.  Neuro-oncology: Amino acid PET for brain tumours - ready for the clinic?

Authors:  Karl-Josef Langen; Colin Watts
Journal:  Nat Rev Neurol       Date:  2016-06-10       Impact factor: 42.937

3.  FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma.

Authors:  Philipp Lohmann; Pantelis Stavrinou; Katharina Lipke; Elena K Bauer; Garry Ceccon; Jan-Michael Werner; Bernd Neumaier; Gereon R Fink; Nadim J Shah; Karl-Josef Langen; Norbert Galldiks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-16       Impact factor: 9.236

4.  Grading glial tumors with amide proton transfer MR imaging: different analytical approaches.

Authors:  Akihiko Sakata; Tomohisa Okada; Akira Yamamoto; Mitsunori Kanagaki; Yasutaka Fushimi; Tsutomu Okada; Toshiki Dodo; Yoshiki Arakawa; Benjamin Schmitt; Susumu Miyamoto; Kaori Togashi
Journal:  J Neurooncol       Date:  2015-01-06       Impact factor: 4.130

5.  Initial contact of glioblastoma cells with existing normal brain endothelial cells strengthen the barrier function via fibroblast growth factor 2 secretion: a new in vitro blood-brain barrier model.

Authors:  Keisuke Toyoda; Kunihiko Tanaka; Shinsuke Nakagawa; Dinh Ha Duy Thuy; Kenta Ujifuku; Kensaku Kamada; Kentaro Hayashi; Takayuki Matsuo; Izumi Nagata; Masami Niwa
Journal:  Cell Mol Neurobiol       Date:  2013-02-06       Impact factor: 5.046

6.  Proton MR spectroscopy of tumefactive demyelinating lesions.

Authors:  Amit M Saindane; Soonmee Cha; Meng Law; Xiaonan Xue; Edmond A Knopp; David Zagzag
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

7.  Multifarious proteomic signatures and regional heterogeneity in glioblastomas.

Authors:  Chul-Kee Park; Ji Hye Jung; Sung-Hye Park; Hee-Won Jung; Byung-Kyu Cho
Journal:  J Neurooncol       Date:  2009-02-15       Impact factor: 4.130

8.  Quantitative characterization of the imaging limits of diffuse low-grade oligodendrogliomas.

Authors:  Chloé Gerin; Johan Pallud; Christophe Deroulers; Pascale Varlet; Catherine Oppenheim; Francois-Xavier Roux; Fabrice Chrétien; Stephen R Thomas; Basile Grammaticos; Mathilde Badoual
Journal:  Neuro Oncol       Date:  2013-06-14       Impact factor: 12.300

9.  Reliability of tumor volume estimation from MR images in patients with malignant glioma. Results from the American College of Radiology Imaging Network (ACRIN) 6662 Trial.

Authors:  Birgit B Ertl-Wagner; Jeffrey D Blume; Donald Peck; Jayaram K Udupa; Benjamin Herman; Anthony Levering; Ilona M Schmalfuss
Journal:  Eur Radiol       Date:  2008-10-17       Impact factor: 5.315

10.  Change detection & characterization: a new tool for imaging informatics and cancer research.

Authors:  Julia W Patriarche; Bradley J Erickson
Journal:  Cancer Inform       Date:  2007-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.